Printer Friendly

DURAMED REPORTS FIRST QUARTER RESULTS FOR 1992

 DURAMED REPORTS FIRST QUARTER RESULTS FOR 1992
 CINCINNATI, May 26 /PRNewswire/ -- E. Thomas Arington, chairman


and president of Duramed Pharmaceuticals, Inc., announced today the company's operating results for the first quarter ended March 31, 1992. Net sales and loss for the quarter were $3,075,000 and $458,000, respectively.
 Arington commented, "Although our bottom line results show a loss, the results for the first quarter were on target with our recovery plan goals, specifically the achievement of break-even at the operating income line. While there is much to be accomplished, we remain focused in our efforts to develop new sources of revenue as well as financing for the company's long-term recovery."
 The following table sets forth Duramed's comparative results for the quarters ended March 31, 1992 and 1991:
 First Quarter Ended
 March 31
 (In thousands except per share 1992 1991
 amounts and shares outstanding)
 Net sales $ 3,075 $ 1,168
 Cost of goods sold 1,974 2,000
 Gross profit (loss) 1,101 (832)
 Operating expenses 1,100 1,454
 Operating income (loss) 1 (2,286)
 Interest expense 460 492
 Net (loss) $ (459) $(2,778)
 Net (loss) per share
 of common stock $ (.07) $ (.44)
 Weighted average number of common
 shares outstanding 6,574,064 6,280,064
 Duramed Pharmaceuticals, Inc. manufactures and sells generic drug products composed of various dosages of prescription and over-the-counter drugs.
 -0- 5/26/92
 /CONTACT: Bill Roberts or John Maginnis, both of Cameron Towey Central, 513-891-1818, for Duramed Pharmaceuticals/ CO: Duramed Pharmaceuticals, Inc. ST: Ohio IN: MTC SU: ERN


BM -- CL007 -- 3662 05/26/92 10:03 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 26, 1992
Words:264
Previous Article:CRAY RESEARCH SELLS FIRST SYSTEM TO FINANCIAL INDUSTRY
Next Article:AEROSPACE WORKERS RALLY TO SAVE AMERICAN JOBS
Topics:


Related Articles
DURAMED REPORTS SECOND QUARTER RESULTS FOR 1992
DURAMED REPORTS 1992 RESULTS; REPORTS DEPARTMENT OF JUSTICE SETTLEMENT; PREDICTS PROFIT FOR FIRST QUARTER
DURAMED REPORTS PROFIT FOR FIRST QUARTER 1993
DURAMED REPORTS SECOND QUARTER RESULTS FOR 1993
DURAMED REPORTS THIRD QUARTER RESULTS FOR 1993
DURAMED EXPECTS CONTINUED IMPROVEMENT IN FOURTH QUARTER
DURAMED REPORTS 1993 RESULTS
DURAMED REPORTS FIRST QUARTER RESULTS FOR 1994
Duramed Pharmaceuticals Reports First Quarter 1997 Results
Duramed Pharmaceuticals Reports Third Quarter Results.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters